H.C. Wainwright Starts Inhibikase Therapeutics Inc (IKT) at Buy
Tweet
Share
E-mailGet Alerts IKT Hot Sheet
Price: $2.41 --0%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Ed White initiates coverage on Inhibikase Therapeutics Inc (NASDAQ: IKT) with a Buy rating.
For an analyst ratings summary and ratings history on Inhibikase Therapeutics Inc click here. For more ratings news on Inhibikase Therapeutics Inc click here.
Shares of Inhibikase Therapeutics Inc closed at $0.58 yesterday.
You May Also Be Interested In
- Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
- Leerink Starts Freenome Inc. (FRNM) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
